Phloroglucinol derivatives from Hypericum species trigger mitochondrial dysfunction in Leishmania amazonensis
Carregando...
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Bioactive molecules isolated from plants are promising sources for the development of new
therapies against leishmaniasis. We investigated the leishmanicidal activity of cariphenone
A (1), isouliginosin B (2) and uliginosin B (3) isolated from Hypericum species.
Promastigotes and amastigotes of Leishmania amazonensis were incubated with compounds
1–3 at concentrations 1–100 µM for 48 h. The anti-promastigote effect of compounds was also
tested in combinations. The cytotoxicity against macrophages and human erythrocytes were
determined using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
method and hemolysis assay, respectively. The compounds 1–3 showed high leishmanicidal
activity against promastigotes, IC50 values of 10.5, 17.5 and 11.3 µM, respectively.
Synergistic interactions were found to the associations of compounds 1 and 2 [Σ fractional
inhibitory concentration (FIC) = 0.41], and 2 and 3 (ΣFIC = 0.28) on promastigotes. All
Hypericum compounds induced mitochondrial hyperpolarization and reactive oxygen species
production in promastigotes. The compounds showed low cytotoxicity toward mammalian
cells, high selectivity index and killed intracellular amastigotes probably mediated by oxidative
stress. These results indicate that these compounds are promising candidates for the develop ment of drugs against leishmaniasis.
Descrição
Palavras-chave
Cariphenone A, Isouliginosin B, Leishmanicidal activity, Reactive oxygen species, Uliginosin B
Citação
DAGNINO, Ana Paula Aquistapase et al. Phloroglucinol derivatives from Hypericum species trigger mitochondrial dysfunction in Leishmania amazonensis. Parasitology, London, v. 45, n. 9, p. 1199-1209, 2018. DOI: 10.1017/S0031182018000203. Disponível em: https://www.cambridge.org/core/journals/parasitology/issue/80F3C73AC8B71CB6E53744ADDC1B181F. Acesso em: 23 abr. 2025.